Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.508EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.94EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.463EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.357EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.318EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.557EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.119EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.160EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
D.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.447EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.110.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.180EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.155EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.92EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.145EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.120EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.201EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.221EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.410EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.411EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XATEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.85EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.65EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BG.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAZEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used